Stock slips after Q4FY26 results despite 13% profit growth; brokerages stay positive on CDMO and GLP-1 opportunities.

But instead of going great lengths to mooch off other people’s money, they could surely have learnt some lessons from ...

Gland Pharma jumped 15.85 per cent to Rs 2,164.40, while Sun Pharma climbed 1 per cent to Rs 1,896.90. Laurus Labs moved up 0 ...

The custom synthesis business, which constitutes 55 percent of sales, grew 19 percent in FY26. We expect it to grow in high teens CAGR for the coming few years.

By IntelliNews The international pharmaceutical industry relies on a model of globalised production and value chains to ...

Synopsis: Divi’s Laboratories is in focus after reporting Q4 growth, with a 9.5% rise in profit and a 13.4% increase in revenue YoY, along with a ₹30 dividend. However, brokerages are split. Citi and ...

Check out top stocks under brokerages' radar heading into trade today.